|
Curis ، Inc. (CRIS) DCF تقييم
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Curis, Inc. (CRIS) Bundle
تقييم آفاق Curis ، Inc. (CRIS) مثل خبير محنك! تأتي حاسبة DCF هذه (CRIS) مع البيانات المالية المليئة مسبقًا وتوفر مرونة تامة لتعديل نمو الإيرادات ، WACC ، الهوامش ، وغيرها من الافتراضات الحرجة التي تتماشى مع تنبؤاتك.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.0 | 10.8 | 10.6 | 10.2 | 10.0 | 10.0 | 10.1 | 10.1 | 10.1 | 10.1 |
| Revenue Growth, % | 0 | 8.31 | -1.72 | -4.57 | -1.37 | 0.16224 | 0.16224 | 0.16224 | 0.16224 | 0.16224 |
| EBITDA | -27.2 | -24.7 | -40.0 | -50.5 | -45.1 | -10.0 | -10.1 | -10.1 | -10.1 | -10.1 |
| EBITDA, % | -271.59 | -227.68 | -375.42 | -497.05 | -450.35 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .1 | .3 | 1.0 | 1.4 | .3 | .6 | .6 | .6 | .6 | .6 |
| Depreciation, % | 1.25 | 2.96 | 9.26 | 13.69 | 2.54 | 5.94 | 5.94 | 5.94 | 5.94 | 5.94 |
| EBIT | -27.3 | -25.0 | -41.0 | -51.9 | -45.4 | -10.0 | -10.1 | -10.1 | -10.1 | -10.1 |
| EBIT, % | -272.84 | -230.64 | -384.67 | -510.74 | -452.9 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 20.5 | 183.1 | 139.8 | 85.6 | 56.3 | 10.0 | 10.1 | 10.1 | 10.1 | 10.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 3.2 | 3.0 | 3.2 | 3.0 | 2.8 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 |
| Account Receivables, % | 32.43 | 28.08 | 30.28 | 29.28 | 27.88 | 29.59 | 29.59 | 29.59 | 29.59 | 29.59 |
| Inventories | -.1 | -.4 | -2.5 | -2.9 | .0 | -1.1 | -1.1 | -1.1 | -1.1 | -1.1 |
| Inventories, % | -0.93962 | -3.68 | -23.86 | -28.4 | 0 | -11.38 | -11.38 | -11.38 | -11.38 | -11.38 |
| Accounts Payable | 4.5 | 4.2 | 6.4 | 3.2 | 3.2 | 4.1 | 4.2 | 4.2 | 4.2 | 4.2 |
| Accounts Payable, % | 44.63 | 38.45 | 60.26 | 31.42 | 31.65 | 41.28 | 41.28 | 41.28 | 41.28 | 41.28 |
| Capital Expenditure | .0 | -.7 | .0 | -.4 | .0 | -.2 | -.2 | -.2 | -.2 | -.2 |
| Capital Expenditure, % | -0.40984 | -6.25 | 0 | -4.09 | 0 | -2.15 | -2.15 | -2.15 | -2.15 | -2.15 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -31.3 | -29.1 | -45.7 | -55.2 | -45.4 | -10.0 | -10.1 | -10.1 | -10.1 | -10.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -29.9 | -29.3 | -40.5 | -56.9 | -47.9 | -7.7 | -9.7 | -9.7 | -9.7 | -9.7 |
| WACC, % | 27.93 | 27.93 | 27.93 | 27.93 | 27.93 | 27.93 | 27.93 | 27.93 | 27.93 | 27.93 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -23.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -10 | |||||||||
| Terminal Value | -38 | |||||||||
| Present Terminal Value | -11 | |||||||||
| Enterprise Value | -34 | |||||||||
| Net Debt | -24 | |||||||||
| Equity Value | -10 | |||||||||
| Diluted Shares Outstanding, MM | 5 | |||||||||
| Equity Value Per Share | -1.94 |
What You Will Get
- Real CRIS Financial Data: Pre-filled with Curis, Inc.'s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Curis, Inc.'s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Curis Financials: Gain access to precise historical data and future forecasts tailored for Curis, Inc. (CRIS).
- Adjustable Forecast Parameters: Modify highlighted fields such as WACC, growth rates, and profit margins to suit your analysis.
- Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: Utilize visually engaging charts and summaries for a clear representation of your valuation outcomes.
- Designed for All Skill Levels: An intuitive layout crafted for investors, CFOs, and consultants, whether seasoned or new to the field.
How It Works
- Download the Template: Gain immediate access to the Excel-based CRIS DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
- Instant Calculations: The model automatically recalculates Curis, Inc.'s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis.
Why Choose the Curis, Inc. (CRIS) Calculator?
- Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses tailored for Curis, Inc. (CRIS).
- Customizable Inputs: Modify yellow-highlighted cells to explore different investment scenarios.
- Detailed Insights: Automatically computes Curis, Inc.'s (CRIS) intrinsic value and Net Present Value.
- Preloaded Data: Access historical and forecasted data for accurate financial assessments.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focused on Curis, Inc. (CRIS).
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Curis, Inc. (CRIS) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for Curis, Inc. (CRIS).
- Consultants: Deliver professional valuation insights on Curis, Inc. (CRIS) to clients quickly and accurately.
- Business Owners: Understand how biotech companies like Curis, Inc. (CRIS) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Curis, Inc. (CRIS).
What the Template Contains
- Pre-Filled DCF Model: Curis, Inc.’s (CRIS) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Curis, Inc.’s (CRIS) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.